| Schedule of Common Stock Reserved |
As
of June 30, 2026 and December 31, 2025, common stock reserved for future issuance consisted of the following:
Schedule
of Common Stock Reserved
| | |
June 30, 2026 | | |
December 31, 2025 | |
| Common stock warrants outstanding | |
| 2,619,735 | | |
| 314,194 | |
| Common stock options issued and outstanding | |
| 16,798 | | |
| 17,364 | |
| Restricted stock units vested and unreleased | |
| 75 | | |
| — | |
| Shares available for future issuance under the 2023 Equity Incentive Plan | |
| 110,209 | | |
| 6,032 | |
| Shares reserved under the 2023 Employee Stock Purchase Plan | |
| 2,051 | | |
| 2,051 | |
| Common stock reserved
for future issuance | |
| 2,748,868 | | |
| 339,641 | |
|
| Schedule of Outstanding Warrants |
As
of June 30, 2026 and December 31, 2025, the Company has outstanding warrants to purchase 2,619,735 and 314,194 shares of Common Stock,
respectively, consisting of the following:
Schedule
of Outstanding Warrants
| | |
June 30, 2026 | | |
December 31, 2025 | | |
Exercise Price | | |
Issuance date | |
Expiration date |
| Private Warrants to purchase Common Stock(1) | |
| 1,000 | | |
| 1,000 | | |
$ | 22,080.00 | | |
September 12, 2023 | |
September 12, 2028 |
| Public Warrants to purchase Common Stock(2) | |
| 5,990 | | |
| 5,990 | | |
$ | 22,080.00 | | |
September 12, 2023 | |
September 12, 2028 |
| Warrants to purchase Restricted Shares | |
| 210 | | |
| 210 | | |
$ | 2,534.40 | | |
February 21, 2024 | |
February 21, 2029 |
| Warrants to purchase Restricted Shares | |
| 3,125 | | |
| 3,125 | | |
$ | 364.80 | | |
July 28, 2024 | |
July 28, 2027 |
| Placement Agent Warrants to purchase Common Stock | |
| 396 | | |
| 396 | | |
$ | 1,267.20 | | |
April 18, 2024 | |
April 18, 2029 |
| Placement Agent Warrants to purchase Common Stock | |
| 279 | | |
| 279 | | |
$ | 720.00 | | |
June 3, 2024 | |
June 3, 2029 |
| Placement Agent Warrants to purchase Common Stock | |
| 534 | | |
| 534 | | |
$ | 240.00 | | |
October 24, 2024 | |
April 24, 2030 |
| Placement Agent Warrants to purchase Common Stock | |
| 1,156 | | |
| 1,156 | | |
$ | 405.60 | | |
November 15, 2024 | |
May 15, 2030 |
| Placement Agent Warrants to purchase Common Stock | |
| 1,303 | | |
| 1,303 | | |
$ | 204.00 | | |
January 10, 2025 | |
January 10, 2030 |
| Representative Warrants to purchase Common Stock | |
| 10,784 | | |
| 10,784 | | |
$ | 48.00 | | |
August 21, 2025 | |
August 21, 2030 |
| Underwriter Warrants to purchase Common Stock | |
| 37,796 | | |
| — | | |
$ | 10.00 | | |
March 9, 2026 | |
March 9, 2031 |
| Series A Warrants to purchase Common Stock | |
| 3,401 | | |
| 3,401 | | |
$ | 291.84 | | |
April 18, 2024 | |
April 18, 2029 |
| Series B-1 Warrants to purchase Common Stock | |
| 91 | | |
| 91 | | |
$ | 291.84 | | |
June 3, 2024 | |
June 3, 2029 |
| Series C-1 Warrants to purchase Common Stock | |
| 1,123 | | |
| 1,123 | | |
$ | 291.84 | | |
June 3, 2024 | |
June 3, 2029 |
| Series C-1 Warrants to purchase Common Stock | |
| 261 | | |
| 261 | | |
$ | 291.84 | | |
August 8, 2024 | |
August 7, 2029 |
| Series C-1 Warrants to purchase Common Stock | |
| 262 | | |
| 262 | | |
$ | 291.84 | | |
August 16, 2024 | |
August 15, 2029 |
| Series D Warrants to purchase Common Stock | |
| 1,147 | | |
| 1,147 | | |
$ | 291.84 | | |
June 3, 2024 | |
December 3, 2029 |
| Series G Warrants to purchase Common Stock | |
| 31,527 | | |
| 31,527 | | |
$ | 8.00 | | |
March 31, 2025 | |
September 30, 2032 |
| Series H Warrants to purchase Common Stock | |
| 34,353 | | |
| 34,353 | | |
$ | 8.00 – 134.40 | | |
July 10, 2025 | |
January 10, 2031 |
| Series I Warrants to purchase Common Stock | |
| 215,675 | | |
| 215,675 | | |
$ | 8.00 – 32.00 | | |
August 21, 2025 | |
August 21, 2030 |
| Series J Warrants to purchase Common Stock | |
| 755,915 | | |
| — | | |
$ | 4.00 | | |
March 9, 2026 | |
March 9, 2031 |
| Series K Warrants to purchase Common Stock | |
| 755,915 | | |
| — | | |
$ | 4.00 | | |
March 9, 2026 | |
March 9, 2027 |
| Series L Warrants to purchase Common Stock | |
| 755,915 | | |
| — | | |
$ | 4.00 | | |
March 9, 2026 | |
September 9, 2026 |
| Total | |
| 2,619,735 | | |
| 314,194 | | |
| | | |
| |
|
| (1) |
The
Private Warrants (and shares of common stock issued or issuable upon exercise of the Private Warrants) in general, will not be transferable,
assignable or salable until 30 days after the Closing (excluding permitted transferees) and they will not be redeemable under certain
redemption scenarios by us so long as they are held by the Sponsor, Metric or their respective permitted transferees. Otherwise,
the Private Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price,
exercisability and exercise period. If the Private Warrants are held by holders other than the Company’s sponsor, Metric or
their respective permitted transferees, the Private Warrants will be redeemable by the Company under all redemption scenarios and
exercisable by the holders on the same basis as the Public Warrants. |
| (2) |
The
Public Warrants became exercisable 30 days after the closing of the FLAG Merger. Each whole
share of the warrant is exercisable for one share of the Company’s common stock.
The
Company may redeem the outstanding Public Warrants for $1.92 per warrant upon at least 30 days’ prior written notice of redemption
given after the warrants become exercisable, if the reported last sale price of the common stock equals or exceeds $34,560.00 per
share (as adjusted for stock dividends, sub-divisions, reorganizations, recapitalizations and the like) for any 20 trading days within
a 30-trading day period commencing after the warrants become exercisable and ending on the third trading day before the Company sends
the notice of redemption to the warrant holders. Upon issuance of a redemption notice by the Company, the warrant holders may, at
any time after the redemption notice, exercise the public warrants on a cashless basis.
The
Company accounts for the Public Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because
the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability.
The
accounting treatment of derivative financial instruments in accordance with ASC 815 requires that the Company record a derivative
liability upon the closing of the FLAG Merger (see Note 2).
On
October 17, 2024, the Company received notice from the NYSE that the Company’s Public Warrants to purchase common stock are
no longer suitable for listing pursuant to Section 1001 of the NYSE American Company Guide due to the low trading price of such public
warrants, and that the NYSE Regulation has determined to commence proceedings to delist the public warrants. The Public Warrants
may be traded on the OTC Pink Marketplace under the symbol CLDWW. |
|
| Schedule of Warrant Activity |
The
following table summarizes the Company’s aggregate warrant activity for the six months ended June 30, 2026.
Schedule
of Warrant Activity
| | |
Number of Warrants | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual
Life (Years) | |
| Outstanding at January 1, 2026 | |
| 314,194 | | |
$ | 559.52 | | |
| 4.79 | |
| Issued | |
| 2,919,036 | | |
| | | |
| | |
| Exercised | |
| (143,188 | ) | |
| | | |
| | |
| Cancelled | |
| — | | |
| | | |
| | |
| Outstanding at March 31, 2026 | |
| 3,090,042 | | |
$ | 59.84 | | |
| 2.07 | |
| Issued | |
| — | | |
| | | |
| | |
| Exercised | |
| (470,307 | ) | |
| | | |
| | |
| Cancelled | |
| — | | |
| | | |
| | |
| Outstanding at June 30, 2026 | |
| 2,619,735 | | |
$ | 67.15 | | |
| 2.19 | |
The
following table summarizes the Company’s aggregate warrant activity for the six months ended June 30, 2025.
| | |
Number of Warrants | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual
Life (Years) | |
| Outstanding at January 1, 2025 | |
| 56,941 | | |
$ | 2,962.56 | | |
| 3.63 | |
| Issued | |
| 48,616 | | |
| | | |
| | |
| Exercised | |
| — | | |
| | | |
| | |
| Cancelled | |
| — | | |
| | | |
| | |
| Outstanding at March 31, 2025 | |
| 105,557 | | |
$ | 1,658.88 | | |
| 4.13 | |
| Issued | |
| — | | |
| | | |
| | |
| Exercised | |
| (14,209 | ) | |
| | | |
| | |
| Cancelled | |
| (3,598 | ) | |
| | | |
| | |
| Outstanding at June 30, 2025 | |
| 87,750 | | |
$ | 1,963.20 | | |
| 4.80 | |
|